ZNF14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.09159999992248E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.10250039600623E-10 |
Normal-vs-Stage2 |
4.82290000047847E-07 |
Normal-vs-Stage3 |
2.34070000004749E-06 |
Normal-vs-Stage4 |
2.40369999999768E-05 |
Stage1-vs-Stage2 |
6.040800E-01 |
Stage1-vs-Stage3 |
9.836600E-01 |
Stage1-vs-Stage4 |
7.802800E-01 |
Stage2-vs-Stage3 |
6.850800E-01 |
Stage2-vs-Stage4 |
9.904800E-01 |
Stage3-vs-Stage4 |
7.488200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.9318000005496E-07 |
Normal-vs-AfricanAmerican |
3.35439999998854E-07 |
Normal-vs-Asian |
7.04500000003883E-07 |
Caucasian-vs-AfricanAmerican |
5.054200E-01 |
Caucasian-vs-Asian |
7.464600E-01 |
AfricanAmerican-vs-Asian |
7.017800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.01799999985275E-07 |
Normal-vs-Female |
4.73290000002624E-06 |
Male-vs-Female |
1.155090E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.62872999999175E-05 |
Normal-vs-Extreme_Weight |
7.10649999957624E-08 |
Normal-vs-Obese |
2.10850000004204E-06 |
Normal-vs-Extreme_Obese |
2.956700E-04 |
Normal_Weight-vs-Extreme_Weight |
2.090400E-01 |
Normal_Weight-vs-Obese |
9.448200E-01 |
Normal_Weight-vs-Extreme_Obese |
3.569600E-01 |
Extreme_Weight-vs-Obese |
8.752200E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.843200E-01 |
Obese-vs-Extreme_Obese |
1.819160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.52319999999962E-05 |
Normal-vs-Age(41-60Yrs) |
2.0185000000339E-06 |
Normal-vs-Age(61-80Yrs) |
1.22779564293296E-11 |
Normal-vs-Age(81-100Yrs) |
2.60409999996991E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.217600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.718800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.900600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.703700E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.637800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.384200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.31139999970387E-07 |
Normal-VS-Type2 PRCC |
7.56769999998852E-08 |
Normal-VS-KIRP CIMP |
1.563060E-03 |
Normal-VS-Unclassified PRCC |
7.63890000000655E-05 |
Type1 PRCC-VS-Type2 PRCC |
6.229000E-01 |
Type1 PRCC-VS-KIRP CIMP |
7.802600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.498420E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.434200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
8.169900E-02 |
KIRP CIMP-VS-Unclassified PRCC |
5.624600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.23300000104609E-08 |
Normal-vs-N1 |
4.572500E-04 |
Normal-vs-N2 |
5.617100E-04 |
N0-vs-N1 |
1.337590E-02 |
N0-vs-N2 |
2.089800E-02 |
N1-vs-N2 |
5.836600E-03 |
|
|